AMGN

AMGEN Inc

Sep 16 • 10:26AM ET

275.27

+0.87 0.32 %

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Index	DJIA, NDX, S&P 500	P/E	22.52	EPS (ttm)	12.22	Insider Own	0.20%	Shs Outstand	538.30M	Perf Week	-1.68%
Market Cap	148.19B	Forward P/E	12.72	EPS next Y	21.64	Insider Trans	-0.35%	Shs Float	537.30M	Perf Month	-7.15%
Enterprise Value	196.37B	PEG	5.39	EPS next Q	5.04	Inst Own	82.17%	Short Float	2.20%	Perf Quarter	-6.87%
Income	6.62B	P/S	4.26	EPS this Y	6.33%	Inst Trans	0.59%	Short Ratio	5.24	Perf Half Y	-13.21%
Sales	34.76B	P/B	19.95	EPS next Y	2.59%	ROA	7.40%	Short Interest	11.80M	Perf YTD	5.61%
Book/sh	13.80	P/C	18.46	EPS next 5Y	4.18%	ROE	99.14%	52W High	339.17 -18.84%	Perf Year	-16.60%
Cash/sh	14.91	P/FCF	13.97	EPS past 3/5Y	-9.75% -10.10%	ROIC	10.82%	52W Low	253.30 8.67%	Perf 3Y	11.13%
Dividend Est.	9.62 (3.50%)	EV/EBITDA	12.90	Sales past 3/5Y	8.54% 7.40%	Gross Margin	68.86%	Volatility	1.88% 1.78%	Perf 5Y	12.09%
Dividend TTM	9.39 (3.41%)	EV/Sales	5.65	EPS Y/Y TTM	110.67%	Oper. Margin	27.90%	ATR (14)	5.33	Perf 10Y	78.10%
Dividend Ex-Date	Aug 22, 2025	Quick Ratio	0.98	Sales Y/Y TTM	13.10%	Profit Margin	19.04%	RSI (14)	36.71	Recom	2.39
Dividend Gr. 3/5Y	8.53% 9.18%	Current Ratio	1.31	EPS Q/Q	91.96%	SMA20	-3.46%	Beta	0.48	Target Price	310.92
Payout	119.05%	Debt/Eq	7.57	Sales Q/Q	10.01%	SMA50	-5.71%	Rel Volume	0.72	Prev Close	274.40
Employees	28000	LT Debt/Eq	7.24	Earnings	Aug 05 AMC	SMA200	-4.33%	Avg Volume	2.25M	Price	275.27
IPO	Jun 17, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.98% 2.72%	Trades		Volume	303,465	Change	0.32%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270

Show Previous Ratings

Today 09:09AM	Stock Market Today: Dow Wavers Amid Surprise Retail Sales; Dave & Busters Plunges (Live Coverage) (Investor's Business Daily)
Sep-15-25 03:31PM	Stock Market Today: Indexes Up As Chips Fall On China; Buffett Stock Tests Entry (Live Coverage) (Investor's Business Daily)
02:40PM	Stock Market Today: Dow Steadies, Nasdaq Up But These Chip Stocks Fall On China Move; Gold Stock Hits Entry (Live Coverage) (Investor's Business Daily)
01:44PM	Stock Market Today: Dow, Nasdaq Gain As Uber Clears Entry; Gold Stock Hits Entry (Live Coverage) (Investor's Business Daily)
11:53AM	Why Californias biopharma boom is critical for logistics (FreightWaves)
11:08AM	Loading…
11:08AM	Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now? (Zacks)
09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:14AM	Samsung Biologics, Amgen and Biocon invest in US pharma sites (Manufacturing Dive)
Sep-14-25 07:15AM	2 Healthcare Dividend Stocks to Buy and Hold (Motley Fool)
01:17AM	Guggenheim Maintains a Hold on Amgen Inc. (AMGN) (Insider Monkey)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Sep-11-25 12:49PM	Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab (Insider Monkey)
10:02AM	Where Does VKTX Stock Stand After the Obesity Pill Setback? (Zacks)
Sep-10-25 10:28AM	Is NVO's Major Restructuring Plan an Indication to Sell the Stock? (Zacks)
07:33AM	Kriya, Odyssey secure megarounds; Amgen boosts R&D leadership (BioPharma Dive)
03:06PM	Loading…
Sep-09-25 03:06PM	Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis (Benzinga)
07:22AM	Amgen and Kyowa Kirin report preliminary outcomes from AD treatment trial (Clinical Trials Arena)
Sep-08-25 09:06PM	If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today (Motley Fool)
08:04PM	AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (PR Newswire)
07:33PM	Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Sep-07-25 10:24AM	William Blair Reiterates a Buy on Amgen Inc (AMGN) (Insider Monkey)
Sep-04-25 10:00PM	How Much Would It Take To Earn $100 A Month From Amgen Stock (Benzinga)
04:01PM	AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
02:54PM	Nvidia Invests in Honeywells Quantinuum. What It Means for D-Wave, IonQ, and Quantum Stocks. (Barrons.com)
02:46PM	Biotech company Amgen set to build $600-million research center in Thousand Oaks (LA Times)
02:36PM	Why Is Sanofi Stock Falling Thursday? (Benzinga)
09:25AM	Nvidia Investment In Honeywell's Quantinuum Sends Quantum Computing Stocks Up (Investor's Business Daily)
07:00AM	Nvidias Venture Arm Invests in Honeywells Quantinuum (Bloomberg)
Sep-02-25 04:25PM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
11:12AM	Leerink Partners Maintains a Hold on Amgen (AMGN) (Insider Monkey)
10:40AM	Loading…
10:40AM	Nio, Signet Jewelers, Amgen: Trending Tickers (Yahoo Finance Video)
09:01AM	AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS (PR Newswire)
08:20AM	Amgen to invest $600M in new US center; Sanofi drug for ITP approved (BioPharma Dive)
03:29AM	Amgen Inc. (AMGN)'s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential (Insider Monkey)
Sep-01-25 04:59PM	Here's What Jim Cramer Wishes Amgen Inc. (AMGN) Should Do To Its Drug That Hurts Like A "Banshee" (Insider Monkey)
12:11PM	Investing in the Age of Longevity: Silver Economy Stocks in Focus (Zacks)
11:05AM	Is Amgen Stock Underperforming the S&P 500? (Barchart)
09:40AM	Here's Why Amgen (AMGN) is a Strong Value Stock (Zacks)
12:31AM	2 Profitable Stocks Worth Your Attention and 1 We Avoid (StockStory)
Aug-31-25 12:10AM	Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating (Insider Monkey)
Aug-29-25 04:01PM	AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE (PR Newswire)
05:40AM	Amgen partners with Veeva Systems to enhance clinical trial processes (Clinical Trials Arena)
Aug-28-25 04:29AM	2 Dividend Stocks to Hold for the Next 10 Years (Motley Fool)
Aug-27-25 01:55PM	Calls of the Day: Micron, DoorDash, Amer Sports, Amgen, Merck and Costco (CNBC TV)
08:11AM	Does Lilly's New Obesity Pill Data Put It Back in the Weight Game? (Zacks)
Aug-26-25 08:06AM	AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock? (Zacks)
Aug-25-25 04:37PM	Dow Loses About 350 Points After Record-Breaking Run (The Wall Street Journal)
01:19PM	BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up (Benzinga)
09:10AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
09:00AM	REPATHA NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C (PR Newswire)
08:39AM	J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy? (Zacks)
08:29AM	Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales (BioPharma Dive)
06:33AM	Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug (Reuters)
Aug-22-25 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
08:49AM	Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans? (Zacks)
Aug-21-25 06:55PM	ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment (Exec Edge)
09:18AM	Can J&J Navigate Stelara, Talc Suits, Tariff & Other Headwinds? (Zacks)
Aug-20-25 05:21AM	3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade (Motley Fool)
Aug-18-25 09:13AM	Lilly Stock Down 5% This Month: Should You Buy the Dip? (Zacks)
Aug-15-25 09:50AM	SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease (Zacks)
Aug-14-25 09:40AM	Why Amgen (AMGN) is a Top Value Stock for the Long-Term (Zacks)
Aug-13-25 04:04PM	Zevra Therapeutics Crashes, Reversing 89% Run. Why It Could Be An 'Overreaction.' (Investor's Business Daily)
10:51AM	Zevra Reported Its First-Ever Quarterly Profit. Why Shares Of The Top 6% Stock Crashed. (Investor's Business Daily)
10:47AM	Novo Nordisk Rises 6% So Far in August: How to Play the Stock (Zacks)
09:33AM	Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB (GlobeNewswire)
Aug-12-25 11:59PM	5 Insightful Analyst Questions From Amgen's Q2 Earnings Call (StockStory)
11:43PM	AMGN Q2 Deep Dive: Volume Growth, Pipeline Progress, and Guidance Raise Meet Investor Skepticism (StockStory)
02:57AM	Puerto Ricos ongoing journey from manufacturing hub to innovation enterprise (Pharma Voice)
Aug-11-25 08:20PM	Amgen Announces Bemarituzumab's Successful Phase 3 Results in FGFR2b+ Gastric Cancer (Insider Monkey)
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
02:00AM	Gilead Stock Is Closing In on an All-Time High. The Case for More Upside. (Barrons.com)
02:00AM	Gilead Sciences Is Closing In on an All-Time High. The Case for More Upside. (Barrons.com)
Aug-08-25 10:47AM	Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season (Zacks)
Aug-07-25 11:32AM	LLY Stock Sinks Despite Q2 Earnings Beat as Obesity Pill Disappoints (Zacks)
Aug-06-25 04:23PM	Why S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise Quarter (Investor's Business Daily) -5.14%
04:01PM	NRG Energy, Amgen, Arista Networks: Trending Tickers (Yahoo Finance Video)
02:19PM	Amgen Stock Sinks As Market Eyes MariTide's Next Move (Benzinga)
12:58PM	Tevas Ajovy becomes first migraine prevention drug approved for children (Pharmaceutical Technology)
10:52AM	Stock Market Today: Dow Edges Up As Fed Officials Signal Shifts; Nvidia Rival Dives On Earnings (Live Coverage) (Investor's Business Daily)
09:51AM	Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly (Zacks)
09:45AM	Stocks to Watch Wednesday: Disney, AMD, Super Micro, Rivian (The Wall Street Journal)
09:03AM	Analyst Report: Amgen Inc. (Morningstar Research)
08:30AM	Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators (PR Newswire)
07:00AM	OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee (GlobeNewswire)
03:26AM	Amgen Inc (AMGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Robust Pipeline ... (GuruFocus.com)
Aug-05-25 07:31PM	Amgen's (NASDAQ:AMGN) Q2: Beats On Revenue (StockStory)
06:02PM	Small-Caps Stay Higher, Other Indexes Dwindle (Zacks)
06:00PM	Stocks to Watch Afterhours: AMD, Amgen, Snap (The Wall Street Journal)
06:00PM	Amgen (AMGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:23PM	Amgen beats on Q2 revenue, slightly raises guidance (CNBC TV)
05:15PM	Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:49PM	Amgen Beats Second-Quarter Expectations, So Why Are Shares Diving? (Investor's Business Daily)
04:49PM	Amgen Posts Higher Profit, Revenue On Sales Growth Among Products (The Wall Street Journal)
04:36PM	Amgen inches lower premarket despite second-quarter earnings beat (Investing.com)
04:16PM	Amgen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Will Amgen, Already Above Its 50-Day Line, Break Out On This Earnings News? (Investor's Business Daily)
04:02PM	Amgen profit rises, weight-loss data expected in 4th quarter (Reuters)
04:01PM	AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
11:03AM	Trade Deficit Narrowed More Than Expected (Zacks)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM
Khosla Rachna	SVP, Business Development	Jun 05 '25	Sale	289.68	1,500	434,520	8,162	Jun 06 07:49 PM
Khosla Rachna	Officer	Jun 05 '25	Proposed Sale	290.00	1,500	435,000		Jun 05 12:24 PM
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM
Grygiel Nancy A.	SVP & CCO	Feb 05 '25	Sale	304.47	1,589	483,808	7,210	Feb 06 08:54 PM
Grygiel Nancy A.	Officer	Feb 05 '25	Proposed Sale	304.47	1,589	483,800		Feb 05 12:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience